Education
About Us
Working with TipRanks
Follow Us
CVS Health Corp (GB:0HRS)
LSE:0HRS
0HRS Stock Chart & Stats
$72.64
$0.05(0.12%)
At close: 4:00 PM EST
$72.64
$0.05(0.12%)
Day’s Range― - ―
52-Week Range$58.20 - $85.80
Previous CloseN/A
Volume7.48K
Average Volume (3M)4.07K
Market Cap
$91.42B
Enterprise Value$176.50B
Total Cash (Recent Filing)$10.66B
Total Debt (Recent Filing)$93.59B
Price to Earnings (P/E)56.9
Beta0.34
Next Earnings
May 06, 2026EPS Estimate
2.23Next Dividend Ex-DateN/A
Dividend Yield3.39%
Share Statistics
EPS (TTM)1.09
Shares Outstanding1,272,211,000
10 Day Avg. Volume2,789
30 Day Avg. Volume4,071
Financial Highlights & Ratios
PEG Ratio-0.92
Price to Book (P/B)1.34
Price to Sales (P/S)0.25
P/FCF Ratio12.88
Enterprise Value/Market Cap1.93
Enterprise Value/Revenue0.44
Enterprise Value/Gross Profit3.19
Enterprise Value/Ebitda17.90
Forecast
1Y Price Target
$96.00Price Target Upside32.16% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering15
EPS Forecast (FY)7.17
Revenue Forecast (FY)$404.96B
Bulls Say, Bears Say
Bulls Say
Medicare Advantage Margin RecoveryAnalyst expects disciplined pricing and benefit adjustments to drive improvement in Medicare Advantage margins, supporting earnings growth even if membership is pared back.
Regulatory Clarity For Pharmacy BusinessAnalyst sees passage of pharmacy benefit manager reform and a major FTC settlement as removing regulatory overhang for the pharmacy benefit management business, which could support a valuation re-rating for the stock.
Retail And Pharmacy Care Operational TailwindsStronger retail market share, large retail script purchases, and a shift toward cost-based pharmacy reimbursement are cited as drivers that can bolster pharmacy care segment operating income.
Bears Say
Elevated Medical Costs And Cash Flow ConstraintsElevated medical costs across product lines, combined with lowered cash flow expectations from payment timing and working capital shifts, could constrain near-term profitability and cash availability.
Medicare Advantage Payment And Risk-adjustment ChangesProposed Medicare Advantage payment reductions and a new risk-adjustment model that excludes certain chart reviews would lower reimbursements and pose a significant headwind to Medicare Advantage margins and care delivery revenue.
Ongoing PBM Margin PressureShift toward fee-based compensation and continued margin pressure in the pharmacy benefit manager business are expected to keep near-term earnings growth modest.
CVS Health News
0HRS FAQ
What was CVS Health Corp’s price range in the past 12 months?
CVS Health Corp lowest share price was $58.20 and its highest was $85.80 in the past 12 months.
What is CVS Health Corp’s market cap?
CVS Health Corp’s market cap is $91.42B.
When is CVS Health Corp’s upcoming earnings report date?
CVS Health Corp’s upcoming earnings report date is May 06, 2026 which is in 46 days.
How were CVS Health Corp’s earnings last quarter?
CVS Health Corp released its earnings results on Feb 10, 2026. The company reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.003 by $0.087.
Is CVS Health Corp overvalued?
According to Wall Street analysts CVS Health Corp’s price is currently Undervalued.
Does CVS Health Corp pay dividends?
CVS Health Corp pays a Quarterly dividend of $0.665 which represents an annual dividend yield of 3.39%. See more information on CVS Health Corp dividends here
What is CVS Health Corp’s EPS estimate?
CVS Health Corp’s EPS estimate is 2.23.
How many shares outstanding does CVS Health Corp have?
CVS Health Corp has 1,272,211,000 shares outstanding.
What happened to CVS Health Corp’s price movement after its last earnings report?
CVS Health Corp reported an EPS of $1.09 in its last earnings report, beating expectations of $1.003. Following the earnings report the stock price went down -1.851%.
Which hedge fund is a major shareholder of CVS Health Corp?
Currently, no hedge funds are holding shares in GB:0HRS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CVS Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$96.00 (32.16% Upside)
$96.00 (32.16% Upside)
Blogger Sentiment
Bullish
GB:0HRS Sentiment 81%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth $1.3K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
12.19%
12-Months-Change
Fundamentals
Return on Equity
2.34%
Trailing 12-Months
Asset Growth
0.09%
Trailing 12-Months
Company Description
CVS Health Corp
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
0HRS Company Deck
0HRS Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call highlighted multiple clear operational and financial improvements across the enterprise — strong revenue growth, meaningful EPS and cash‑flow outperformance for 2025, substantial YoY profit recovery at Aetna, robust pharmacy momentum (same‑store and script gains), sizable client savings and strategic wins (cost‑based reimbursement, TrueCost, HUMIRA biosimilar adoption). Key challenges include an unfavorable preliminary 2027 Medicare Advantage rate notice, a Q4 adjusted operating loss in Health Care Benefits driven by Part D seasonality, membership declines in certain blocks, regulatory uncertainty for PBM dynamics and persistent elevated medical cost trends. Overall, the positive operational momentum, reaffirmed 2026 guidance, and improved cash and leverage profile outweigh the headwinds, though management noted material risks they are actively addressing.View all GB:0HRS earnings summaries0HRS Revenue Breakdown
46.57% Health Services
35.05% Health Care Benefits
33.40% Pharmacy & Consumer Wellness
0.12% Corporate/ Other
0HRS Stock 12 Month Forecast
Average Price Target
$96.00
▲(32.16% Upside)
Technical Analysis
Options Prices
Currently, No data available
---